The Trendlines Group Ltd. (TRNGF)

OTCMKTS · Delayed Price · Currency is USD
0.0300
-0.0228 (-43.18%)
At close: Feb 18, 2025
Market Cap63.12M +131.8%
Revenue (ttm)9.30M
Net Income1.92M
EPS0.00
Shares Out n/a
PE Ratio32.91
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume320,000
Open0.0300
Previous Close0.0528
Day's Range0.0300 - 0.0300
52-Week Range0.0300 - 0.0564
Beta0.57
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About The Trendlines Group

The Trendlines Group Ltd. is an innovation commercialization company and a private equity and venture capital firm specializing in incubation, seed, start-up, early venture and late venture investments. The firm seeks to invest in food, medtech, clean technology, agrifood, agritechnology, healthcare, life sciences, with a focus on medical devices, biotechnology, and pharmaceuticals, security, medical, and information technology companies. It considers investments in Israel and Singapore. The firm offers business incubation, partner and channel ... [Read more]

Sector Financials
Founded 1993
Employees 20
Stock Exchange OTCMKTS
Ticker Symbol TRNGF

Financial Performance

Financial Statements

News

NICE Surgical Awarded U.S. Patent for Purse-String Stapler

Enables intracorporeal purse-sting suturing, stapling, and resection in a single firing SINGAPORE, July 1, 2026 /PRNewswire/ -- NICE Surgical Solutions Pte Ltd ("NICE Surgical"), a clinical-stage medi...

19 days ago - PRNewsWire

IBI Ag Announces Successful Development of AI-Driven De Novo Protein Design Platform for Bioinsecticides

POC included in vivo insect validation of de novo designed proteins NES TZIONA, Israel, March 10, 2026 /PRNewswire/ -- IBI Ag Ltd. ('IBI Ag'), a leader in sustainable agricultural solutions, has today...

4 months ago - PRNewsWire

IBI Ag Completes $10 Million Series A Round Led by Corteva

This is the second and final tranche of IBI Ag's Series A Round for its novel bioinsecticide platform NESS ZIONA, Israel , Nov. 11, 2025 /PRNewswire/ -- IBI Ag, a pioneering crop protection company de...

8 months ago - PRNewsWire

Escala Secures $4.5M in Funding to Accelerate Global Expansion of Its FDA-Approved Medical Device

Co-financing by the EIC Fund to ramp up women's health solution to POP MISGAV, Israel , June 30, 2025 /PRNewswire/ -- Escala Medical Ltd. ("Escala"), a medical technology company specializing in innov...

1 year ago - PRNewsWire

Arcuro Medical Announces FDA 510(k) Clearance for the SuperBall RC for Rotator Cuff Indications

MINNEAPOLIS and MISGAV, Israel , Feb. 27, 2025 /PRNewswire/ -- Arcuro Medical Ltd., ("Arcuro") today announced that it received FDA 510(k) clearance for its new SuperBall-RC™ system for use in rotator...

1 year ago - PRNewsWire

Limaca's Precision-GI™ Enters US Market

CMS Transitional Pass-Through (TPT) Payment and completion of successful clinical studies position Limaca for US market entry. YOKNEAM, Israel , Feb. 18, 2025 /PRNewswire/ -- Limaca Medical Ltd.

1 year ago - PRNewsWire

IBI Ag Secures $6.1 Million in Funding Round Led by Corteva Inc.

This is the first tranche of a Series A Round for IBI Ag's novel bioinsecticide platform. NES TZIONA, Israel , Feb. 13, 2025 /PRNewswire/ -- IBI Ag, a pioneering crop protection company developing a w...

1 year ago - PRNewsWire

Varana Capital Leads Arcuro Medical's Series A Financing, Driving Strategic Growth in 2025

DENVER , Jan. 6, 2025 /PRNewswire/ -- Varana Capital is pleased to announce their role as lead investor in the initial closing of Arcuro Medical's Series A financing round. This funding round, which i...

1 year ago - PRNewsWire

Limaca's Precision-GI™ Granted CMS Transitional Pass-Through (TPT) Payment

Precision-GI™ FDA Designated Breakthrough product and FDA cleared semi-automated motorized endoscopic biopsy device entering U.S. market YOKNEAM, Israel , Nov. 7, 2024 /PRNewswire/ -- The Centers for ...

1 year ago - PRNewsWire

Vensica Medical Secures $11M in Funding to Support Phase 2 Trials for Overactive Bladder Treatment

Backed by IBF, Merz, and Laborie, Vensica to Advance Needle-Free Delivery of Botulinum Toxin A (Xeomin®) for Minimally Invasive Treatment BROOKLYN, N.Y. , Oct. 28, 2024 /PRNewswire/ -- Vensica Medical...

1 year ago - PRNewsWire

ElastiMed Welcomes Dr. Amir Belson as a Member of the Board of Directors

YOKNEAM, Israel , Oct. 28, 2024 /PRNewswire/ -- ElastiMed Ltd. a leading innovator in wearable medical devices, is proud to announce the appointment of Dr. Amir Belson as a member of its Board of Dire...

1 year ago - PRNewsWire

Arcuro Medical Exceeds 4,000 Case Milestone

Meniscal Repair Innovator Continues U.S. Growth MINNEAPOLIS and MISGAV, Israel , Aug. 5, 2024 /PRNewswire/ --  Arcuro Medical Ltd., ("Arcuro") today announced a key milestone of exceeding 4,000 surgic...

2 years ago - PRNewsWire

Dasyo Welcomes Medical Aesthetics Industry Icon Domenic (Dom) Serafino as Executive Chair

MISGAV, Israel , July 22, 2024 /PRNewswire/ -- Dasyo, a company pioneering innovative noninvasive technologies in medical aesthetics, is thrilled to announce the appointment of Domenic (Dom) Serafino ...

2 years ago - PRNewsWire

Ceretrieve Announces Groundbreaking Success in FIH Ischemic Stroke Cases

Ceretrieve's aspiration catheter demonstrated clots removal, completely restoring blood flow in a single pass. YOKNEAM, Israel , May 28, 2024 /PRNewswire/ -- Ceretrieve announced today the successful ...

2 years ago - PRNewsWire

ZygoFix Receives FDA Clearance for its zLOCK Lumbar Facet Fixation System

MISGAV, Israel , May 6, 2024 /PRNewswire/ -- ZygoFix Ltd. a portfolio company of The Trendlines Group Ltd.

2 years ago - PRNewsWire

Arcuro Medical Appoints Jamal Rushdy CEO

MINNEAPOLIS and MISGAV, Israel , May 1, 2024 /PRNewswire/ -- Arcuro Medical Ltd. (www.arcuromedical.com), a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), today announced the app...

2 years ago - PRNewsWire

Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment

Investors include an undisclosed global strategic investor , ALIVE VC and Agriline MISGAV, Israel , Feb. 14, 2024 /PRNewswire/ -- Vessi Medical Ltd. ("Vessi") announced today that it has closed a Seri...

2 years ago - PRNewsWire

Omeq Medical Receives FDA Regulatory Clearance for its Smart Device for Epidural Injections

Potential to become the standard of care for safer epidural injections.   MISGAV, Israel , May 9, 2023 /PRNewswire/ -- Omeq Medical Ltd.

3 years ago - PRNewsWire

liberDi Receives FDA Regulatory Clearance for its Digital Dialysis System

Potential to become the standard of care for home peritoneal dialysis. MISGAV, Israel , Jan. 4, 2023 /PRNewswire/ -- liberDi Ltd.

3 years ago - PRNewsWire

Collaborative Study by NeuroQuest and AIBL Shows Specific Biomarkers for Alzheimer's Could Lead to Blood-based Screening Tool

Current tests used to diagnose Alzheimer's in its early stages — when intervention offers the most hope — have limited use due to their costs and reliability. This approach identifies disease specific...

3 years ago - PRNewsWire

Trendlines Invests in Celleste Bio to Make Our Chocolate Supply Sustainable

Co-investors include Mondelēz International, Barrel Ventures and Regba Group MISGAV, Israel , Nov. 7, 2022 /PRNewswire/ -- The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced...

4 years ago - PRNewsWire

Biotech Food Colorant Startup Phytolon Closes $14.5 Million Series A Funding Round, Led by DSM Venturing

YOKNEAM ILLIT, Israel , July 7, 2022 /PRNewswire/ -- Phytolon, a developer of fermentation-based natural food colors, announced today it has secured $14.5 million in funding, led by DSM Venturing, to ...

4 years ago - PRNewsWire

Bayer Trendlines Ag Innovation Fund Co-invests with Trendlines in TierraSpec

Cost effective and remote quantification of carbon content in agricultural soil MISGAV, Israel , June 6, 2022 /PRNewswire/ -- The Bayer Trendlines Ag Innovation Fund ("the Fund"), set up by Bayer Crop...

4 years ago - PRNewsWire

Limaca Medical and HekaBio Announce Japan Partnership

The partnership aims to advance precision medicine YOKNEAM, Israel , May 16, 2022 /PRNewswire/ -- Limaca Medical ("Limaca") and HekaBio K.K. announced today that they have inked a strategic partnershi...

4 years ago - PRNewsWire

Limaca Medical Receives FDA Breakthrough Device Designation

Limaca's Precision-GI Endoscopic Biopsy Device Advances Precision Medicine YOKNEAM, Israel, May 2, 2022 /PRNewswire/ -- Limaca Medical ("Limaca") announced today that its Precision-GI™ Endoscopic Ultr...

4 years ago - PRNewsWire